Antidepressant effects of estrogens: A basic approximation

Behavioural Pharmacology

Volumn 21, Issue 5-6, 2010, Pages 451-464

  Estrada Camarena, Erika ^a   López Rubalcava, Carolina ^b   Vega Rivera, Nelly ^a,b   Récamier Carballo, Soledad ^a,b   Fernández Guasti, Alonso ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

17 ethyinyl estradiol; 17 estradiol; antidepressant like action; forced swimming test; noradrenaline; serotonin

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; 17ALPHA ESTRADIOL; CITALOPRAM; CLOMIPRAMINE; COUMESTROL; DESIPRAMINE; DIARYLPROPIONITRILE; DIETHYLSTILBESTROL; ESTRADIOL; ESTRADIOL BENZOATE; ESTRADIOL VALERATE; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETHINYLESTRADIOL; FLUOXETINE; IMIPRAMINE; MOCLOBEMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROTROPHIC FACTOR; RALOXIFENE; SEROTONIN 1A RECEPTOR; SERTRALINE; TAMOXIFEN; TRYPTOPHAN HYDROXYLASE 2; VENLAFAXINE;

DEPRESSION; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SCREENING; ESTROGEN THERAPY; ESTRUS CYCLE; FORCED SWIMMING TEST; GABAERGIC SYSTEM; HUMAN; LATENT PERIOD; LOW DRUG DOSE; MONOAMINERGIC SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; NORADRENERGIC SYSTEM; OVARIECTOMY; PSYCHOPHARMACOLOGY; REVIEW; SEROTONINERGIC SYSTEM; SINGLE DRUG DOSE; THERAPY EFFECT; TREATMENT DURATION;

AGE FACTORS; ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ESTROGENS; HUMANS; RECEPTORS, ESTROGEN; SEX FACTORS; TIME FACTORS;

EID: 77955981527     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32833db7e9     Document Type: Review

References (170)

1. Alves SE, Hoskin E, Lee SJ, Brake WG, Ferguson D, Luine V, et al. (2002). Serotonin mediates CA1 spine density but is not crucial for ovarian steroid regulation of synaptic plasticity in the adult rat dorsal hippocampus. Synapse 45:143-151.
2. Amsterdam J, Garcia-Espana F, Fawcett J, Quitkin F, Reimherr F, Rosenbaum J, Beasley C (1999). Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord 55:11-17.
3. Bäckström T, Andreen L, Birzniece V, Bjorn I, Johansson IM, Nordenstam-Haghjo M, et al. (2003). The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 17:325-342.
4. Banasr M, Hery M, Brezun JM, Daszuta A (2001). Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus. Eur J Neurosci 14:1417-1424.
5. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S (1998). Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 54:105-112.
6. Bëique JC, Lavoie N, de Montigny C, Debonnel G (1998). Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur J Pharmacol 349:129-132.
7. Bëique JC, de Montigny Blier P, Debonnel G (2000). Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat. Neuropharmaco-logy 39:1800-1812.
8. Bekku N, Yoshimura H (2005). Animal model of menopausal depressive-like state in female mice: prolongation of immobility time in the forced swimming test following ovariectomy. Psychopharmacology (Berl) 183:300-307.
9. Belló M, Puentes-Rosas E, Medina-Mora ME, Lozano R (2005). Prevalence and diagnosis of depression in Mexico. Salud Publica Mex 47 (Suppl 1):S4-S11.
10. Berkley KJ, McAllister SL, Accius BE, Winnard KP (2007). Endometriosis-induced vaginal hyperalgesia in the rat: effect of estropause, ovariectomy, and estradiol replacement. Pain 132 (Suppl 1):S150-S159.
11. Bernardi M, Vergoni AV, Sandrini M, Tagliavini S, Bertolini A (1989). Influence of ovariectomy, estradiol and progesterone on the behavior of mice in an experimental model of depression. Physiol Behav 45:1067-1068.
12. Bethea CL, Reddy AP, Tokuyama Y, Henderson JA, Lima FB (2009). Protective actions of ovarian hormones in the serotonin system of macaques. Front Neuroendocrinol 30:212-238.
13. Blier P (2001a). Pharmacology of rapid-onset antidepressant treatment strategies. J Clin Psychiatry 62 (Suppl 15):12-17.
14. Blier P (2001b). Possible neurobiological mechanisms underlying faster onset of antidepressant action. J Clin Psychiatry 62 (Suppl 4):7-11.
15. Blier P, de Montigny C (1994). Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220-226.
16. Borsini F, Meli A (1988). Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94:147-160.
17. Brake WG, Alves SE, Dunlop JC, Lee SJ, Bulloch K, Allen PB, et al. (2001). Novel target sites for estrogen action in the dorsal hippocampus: an examination of synaptic proteins. Endocrinology 142:1284-1289.
18. Carrasco GA, Barker SA, Zhang Y, Damjanoska KJ, Sullivan NR, Garcia F, et al. (2004). Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine1A receptors. Neuroscience 127:261-267.
19. Cavus I, Duman RS (2003). Influence of estradiol, stress, and 5-HT2A agonist treatment on brain-derived neurotrophic factor expression in female rats. Biol Psychiatry 54:59-69.
20. Chakraborty TR, Gore AC (2004). Aging-related changes in ovarian hormones, their receptors, and neuroendocrine function. Exp Biol Med (Maywood) 229:977-987.
21. Chang AS, Chang SM (1999). Nongenomic steroidal modulation of high-affinity serotonin transport. Biochim Biophys Acta 1417:157-166.
22. Chiba S, Suzuki M, Yamanouchi K, Nishihara M (2007). Involvement of granulin in estrogen-induced neurogenesis in the adult rat hippocampus. J Reprod Dev 53:297-307.
23. Choi YS, Lee MY, Sung KW, Jeong SW, Choi JS, Park HJ, et al. (2003). Regional differences in enhanced neurogenesis in the dentate gyrus of adult rats after transient forebrain ischemia. Mol Cells 16:232-238.
24. Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL (2003). Short-term use of estradiol for depression in perimenopausal and post-menopausal women: a preliminary report. Am J Psychiatry 160:1519-1522.
25. Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA (2002). cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22:3262-3268.
26. Coope J (1975). The post-hysterectomy syndrome. Nurs Times 71:1285-1286.
27. Cryan JF, Kelly PH, Neijt HC, Sansig G, Flor PJ, van Der Putten H (2003). Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur J Neurosci 17:2409-2417.
28. Cryan JF, Page ME, Lucki I (2005a). Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 182:335-344.
29. Cryan JF, Valentino RJ, Lucki I (2005b). Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29:547-569.
30. Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, et al. (2001). Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci\USA 98:12796-12801.
31. D'Astous M, Mendez P, Morissette M, Garcia-Segura LM, Di Paolo T (2006). Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Mol Pharmacol 69:1492-1498.
32. Dalla C, Antoniou K, Papadopoulou-Daifoti Z, Balthazart J, Bakker J (2004). Oestrogen-deficient female aromatase knockout (ArKO) mice exhibit depressive-like symptomatology. Eur J Neurosci 20:217-228.
33. De Chaves G, Moretti M, Castro AA, Dagostin W, da Silva GG, Boeck CR, et al. (2009). Effects of long-term ovariectomy on anxiety and behavioral despair in rats. Physiol Behav 97:420-425.
34. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, et al. (2009). In vivo effects of a GPR30 antagonist. Nat Chem Biol 5:421-427.
35. Detke MJ, Lucki I (1996). Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43-46.
36. Detke MJ, Rickels M, Lucki I (1995). Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepres-sants. Psychopharmacology (Berl) 121:66-72.
37. Detke MJ, Johnson J, Lucki I (1997). Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 5:107-112.
38. Dhar V, Murphy BE (1990). Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS). Psycho-neuroendocrinology 15:489-493.
39. Dhir A, Kulkarni SK (2008). Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems. Can J Physiol Pharmacol 86:726-735.
40. Ditkoff EC, Crary WG, Cristo M, Lobo RA (1991). Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78:991-995.
41. Donner N, Handa RJ (2009). Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 163:705-718.
42. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
43. Duman RS, Malberg J, Thome J (1999). Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 46:1181-1191.
44. Encinas JM, Vaahtokari A, Enikolopov G (2006). Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci\USA 103:8233-8238.
45. Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C (2003). Anti-depressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology 28:830-838.
46. Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C (2004). Interaction between estrogens and antidepressants in the forced swimming test in rats. Psychopharmacology (Berl) 173:139-145.
47. Estrada-Camarena E, Ferná ndez-Guasti A, Ló pez-Rubalcava C (2006a). Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test. Neuropsychopharmacology 31:247-255.
48. Estrada-Camarena E, López-Rubalcava C, Fernández-Guasti A (2006b). Facilitating antidepressant-like actions of estrogens are mediated by 5-HT1A and estrogen receptors in the rat forced swimming test. Psychoneuroendocrinol-ogy 31:905-914.
49. Estrada-Camarena E, Rivera NM, Berlanga C, Fernández-Guasti A (2008a). Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test. Psychopharmacology (Berl) 201:351-360.
50. Estrada EM, Marquez Baltazar S, López-Rubalcava C (2008b). Influence of post-ovariectomy time on the antidepressant-like actions of 17 beta-estradiol and ethynil-estradiol in the Forced Swimming Test. Program No. 56.3/BB8. Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience.
51. Filardo EJ, Thomas P (2005). GPR30: a seven transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16:362-367.
52. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI (2002). Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84.
53. Galea LA (2008). Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents. Brain Res Rev 57:332-341.
54. Galea LA, Wide JK, Barr AM (2001). Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res 122:1-9.
55. Galea LA, Lee TT, Kostaras X, Sidhu JA, Barr AM (2002). High levels of estradiol impair spatial performance in the Morris water maze and increase depressive-like behaviors in the female meadow vole. Physiol Behav 77:217-225.
56. Garlow S, Nemeroff C (1999). The neurochemestry of mood disorders: clinical studies. Neurobiology of mental illness. 1st ed. Oxford: Oxford University Press; pp. 348-364.
57. Gerrits M, Grootkarijn A, Bekkering BF, Bruinsma M, Den Boer JA, Ter Horst GJ (2005). Cyclic estradiol replacement attenuates stress-induced c-Fos expression in the PVN of ovariectomized rats. Brain Res Bull 67:147-155.
58. Ghraf R, Michel M, Hiemke C, Knuppen R (1983). Competition by monophenolic estrogens and catecholestrogens for high-affinity uptake of 3H(-)-norepi-nephrine into synaptosomes from rat cerebral cortex and hypothalamus. Brain Res 277:163-168.
59. Grigoriadis S, Robinson GE (2007). Gender issues in depression. Ann Clin Psychiatry 19:247-255.
60. Halbreich U, Kahn LS (2001). Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs 15:797-817.
61. Halbreich U, Endicott J, Goldstein S, Nee J (1986). Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 74:576-586.
62. Hamilton JA, Parry BL, Blumenthal SJ (1988). The menstrual cycle in context, II: human gonadal steroid hormone variability. J Clin Psychiatry 49:480-484.
63. Hervas I, Queiroz CM, Adell A, Artigas F (2000). Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. Br J Pharmacol 130:160-166.
64. Herynk M, Fuqua S (2004). Estrogen receptor mutations in human disease. Endocr Rev 25:869-898.
65. Hiemke C, Bruder D, Poetz B, Ghraf R (1985). Sex-specific effects of estradiol on hypothalamic noradrenaline turnover in gonadectomized rats. Exp Brain Res 59:68-72.
66. Holmes MM,Wide JK, Galea LA (2002). Low levels of estradiol facilitate, whereas high levels of estradiol impair, working memory performance on the radial arm maze. Behav Neurosci 116:928-934.
67. Hunsberger J, Austin DR, Henter ID, Chen G (2009). The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci 11:333-348.
68. Jackson A, Uphouse L (1998). Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action. Brain Res 796:299-302.
69. Joffe H, Groninger H, Soares CN, Nonacs R, Cohen LS (2001). An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy. J Womens Health Gend Based Med 10:999-1004.
70. Karahancer M, Cirpan T, Kanit L, Terek MC, Dikmen Y, Ozsener S (2008). The effects of raloxifen on depression and cognition in ovariectomized rats. Fert Steril 89:240-242.
71. Kirby LG, Lucki I (1997). Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindo-leacetic acid in the rat. J Pharmacol Exp Ther 282:967-976.
72. Kitada Y, Miyauchi T, Kanazawa Y, Nakamichi H, Satoh S (1983). Involvement of alpha-and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test. Neuropharmacology 22:1055-1060.
73. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y (1979). Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36:550-554.
74. Kreiss DS, Lucki I (1995). Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 274:866-876.
75. Kugaya A, Sanacora G (2005). Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 10:808-819.
76. Kuiper GG, Gustafsson JA (1997). The novel estrogen receptor-beta subtype: potential role in the cell-and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett 410:87-90.
77. Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870.
78. Lee SJ, Campomanes CR, Sikat PT, Greenfield AT, Allen PB, McEwen BS (2004). Estrogen induces phosphorylation of cyclic AMP response element binding (pCREB) in primary hippocampal cells in a time-dependent manner. Neuroscience 124:549-560.
79. Li Q, Muma NA, Van de Kar LD (1996). Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. J Pharmacol Exp Ther 279:1035-1042.
80. Li Q, Muma NA, Battaglia G, Van de Kar LD (1997a). Fluoxetine gradually increases 125I DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq-and G11-proteins. Brain Res 775:225-228.
81. Li X, Schwartz PE, Rissman EF (1997b). Distribution of estrogen receptor-betalike immunoreactivity in rat forebrain. Neuroendocrinology 66:63-67.
82. Linner L, Arborelius L, Nomikos GG, Bertilsson L, Svensson TH (1999). Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2-adrenoceptor blockade. Biol Psychiatry 46:766-774.
83. Linthorst AC, Penalva RG, Flachskamm C, Holsboer F, Reul JM (2002). Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism. Eur J Neurosci 16:2441-2452.
84. Liu HK, Belz T, Bock D, Takacs A, Wu H, Lichter P, et al. (2008). The nuclear receptor tailless is required for neurogenesis in the adult subventricular zone. Genes Dev 22:2473-2478.
85. Lopez-Jaramillo P, Teran E, Molina G, Rivera J, Lozano A (1996). Oestrogens and depression. Lancet 348:135-136.
86. ́ López-Rubalcava C, Oikawa-Sala J, Chávez-Alvarez K, Estrada-Camarena E (2005). Analysis of the participation of the serotonergic system in the antidepressant-like action of 17beta-estradiol in the forced swimming test (fst): presynaptic or postsynaptic actions. Program No. 567.12. Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience.
87. López-Rubalcava C, Vega Rivera NM, Cruz-Mart?́nez JJ, Estrada-Camarena E (2007). Participation of both estrogen and alpha2-adrenergic receptors, in the antidepressant-like actions of ethynil-estradiol in rats tested in the forced swimming test. 12th Biennial meeting of the European Behavioral Pharmacology Society. Tubingen Germany: Behavioural Society Pharmacology; 18:S19-S19.
88. López-Rubalcava C, Mostalac-Preciado C, Estrada-Camarena E (2009). The rat forced swimming test: an animal model for the study of the antidepressant drugs. Chapter 10. In: Rocha-Arrieta LL, Granados-Soto V, editors. Models of neuropharmacology. India: Ransworld Res Network; pp.149-168.
89. Lucki I (1997). The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523-532.
90. Malberg JE, Duman RS (2003). Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neurop-sychopharmacology 28:1562-1571.
91. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110.
92. Margeat E, Bourdoncle A, Margueron R, Poujol N, Cavaillès V, Royer C (2003). Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta. J Mol Biol 326:77-92.
93. Martínez-Mota L, Cruz-Martinez JJ, Marquez-Baltazar S, Fernandez-Guasti A (2008). Estrogens participate in the antidepressant-like effect of desipramine and fluoxetine in male rats. Pharmacol Biochem Behav 88:332-340.
94. Mazzucco CA, Lieblich SE, Bingham BI, Williamson MA, Viau V, Galea LA (2006). Both estrogen receptor alpha and estrogen receptor beta agonists enhance cell proliferation in the dentate gyrus of adult female rats. Neuroscience 141:1793-1800.
95. McEwen B, Akama K, Alves S, Brake WG, Bulloch K, Lee S, et al. (2001). Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation. Proc Natl Acad Sci\USA 98:7093-7100.
96. Mize AL, Alper RH (2000). Acute and long-term effects of 17beta-estradiol on G(i/o) coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [35S]GTPgammaS binding. Brain Res 859:326-333.
97. Mize AL, Alper RH (2002). Rapid uncoupling of serotonin-1A receptors in rat hippocampus by 17beta-estradiol in vitro requires protein kinases A and C. Neuroendocrinology 76:339-347.
98. Mize AL, Poisner AM, Alper RH (2001). Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function. Neuroendocrinology 73:166-174.
99. Mombereau C, Kaupmann K, Froestl W, Sansig G, van der Putten H, Cryan JF (2004). Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety-and antidepressant-like behavior. Neuropsychopharmacology 29:1050-1062.
100. Mongeau R, Blier P, de Montigny C (1997). The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 23:145-195.
101. Monje P, Boland R (2001). Subcellular distribution of native estrogen receptor- and- isoforms in rabbit uterus and ovary. J Cell Biochem 82:467-479.
102. Monroe SM, Reid MV (2008). Gene-environment interactions in depression research: genetic polymorphisms and life-stress polyprocedures. Psychol Sci 19:947-956.
103. Montgomery JC, Appleby L, Brincat M, Versi E, Tapp A, Fenwick PB, Studd JW (1987). Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1:297-299.
104. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF (2005). Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry 66:774-780.
105. Nestler EJ, Terwilliger RZ, Duman RS (1989). Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J Neurochem 53:1644-1647.
106. Nibuya M, Morinobu S, Duman RS (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547.
107. Nibuya M, Nestler EJ, Duman RS (1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16:2365-2372.
108. Nowakowska E, Kus K (2005). Antidepressant and memory affecting influence of estrogen and venlafaxine in ovariectomized rats. Arzneimittelforschung 55:153-159.
109. Okada M, Hayashi N, Kometani M, Nakao K, Inukai T (1997). Influences of ovariectomy and continuous replacement of 17beta-estradiol on the tail skin temperature and behavior in the forced swimming test in rats. Jpn J Pharmacol 73:93-96.
110. Oppenheim G (1983). Estrogen in the treatment of depression: neuropharma-cological mechanisms. Biol Psychiatry 18:721-725.
111. Ormerod BK, Lee TT, Galea LA (2003). Estradiol initially enhances but subsequently suppresses (via adrenal steroids) granule cell proliferation in the dentate gyrus of adult female rats. J Neurobiol 55:247-260.
112. Ormerod BK, Lee TT, Galea LA (2004). Estradiol enhances neurogenesis in the dentate gyri of adult male meadow voles by increasing the survival of young granule neurons. Neuroscience 128:645-654.
113. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997). Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305-1322.
114. Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I (1999). Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 147:162-167.
115. Pittenger C, Duman RS (2008). Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33:88-109.
116. Porsolt RD, Le Pichon M, Jalfre M (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730-732.
117. Porsolt RD, Anton G, Blavet N, Jalfre M (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391.
118. Raap DK, Van de Kar LD (1999). Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci 65:1217-1235.
119. Raap DK, DonCarlos L, Garcia F, Muma NA, Wolf WA, Battaglia G, Van de Kar LD (2000). Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus. Neuropharmacology 39:1823-1832.
120. Rachman IM, Unnerstall JR, Pfaff DW, Cohen RS (1998). Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test. Proc Natl Acad Sci\USA 95:1 3941-13946.
121. Riecher-Rössler A, de Geyter C (2007). The forthcoming role of treatment with oestrogens in mental health. Swiss Med Wkly 137:565-572.
122. Robichaud M, Debonnel G (2006). Allopregnanolone and ganaxolone increase the firing activity of dorsal raphe nucleus serotonergic neurons in female rats. Int J Neuropsychopharmacol 9:191-200.
123. Rocha BA, Fleischer R, Schaeffer JM, Rohrer SP, Hickey GJ (2005). 17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology (Berl) 179:637-643.
124. Romano-Torres M, Fernandez-Guasti A (2010). Estradiol valerate elicits antidepressant-like effects in middle-aged female rats under chronic mild stress. Behav Pharmacol 21:104-111.
125. Rossi DV, Dai Y, Thomas P, Carrasco GA, Doncarlos LL, Muma NA, Li Q (2010). Estradiol-induced desensitization of 5-HT(1A) receptor signaling in the para-ventricular nucleus of the hypothalamus is independent of estrogen receptor-beta. Psychoneuroendocrinology. doi:10.1016/j.psyneun.2010.01.003.
126. Saletu B, Brandstatter N, Metka M, Stamenkovic M, Anderer P, Semlitsch HV, et al. (1995). Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacology (Berl) 122:321-329.
127. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-809.
128. Scharfman HE, Maclusky NJ (2005). Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue? Trends Neurosci 28:79-85.
129. Schildkraut JJ (1965). The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509-522.
130. Schmidt HD, Duman RS (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18:391-418.
131. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. (2000). Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183:414-420.
132. Schmidt HD, Banasr M, Duman RS (2008). Future antidepressant targets: neurotrophic factors and related signaling cascades. Drug Discov Today Ther Strateg 5:151-156.
133. Schneider WH, Schmid R, Spona J (1977). Central and peripheral actions of an oral contraceptive with reduced oestrogen content. Wien Klin Wochenschr 89:311-313.
134. Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS; Fluoxetine Collaborative Study Group (1997). Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am J Geriatr Psychiatry 5:97-106.
135. Schneider LS, Small GW, Clary CM (2001). Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am J Geriatr Psychiatry 9:393-399.
136. Sell SL, Craft RM, Seitz PK, Stutz SJ, Cunningham KA, Thomas ML (2008). Estradiol-sertraline synergy in ovariectomized rats. Psychoneuroendocrinol-ogy 33:1051-1060.
137. Shapira B, Oppenheim G, Zohar J, Segal M, Malach D, Belmaker RH (1985). Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psychiatry 20:576-579.
138. Shen C, Li H, Meller E (2002). Repeated treatment with antidepressants differentially alters 5-HT1A agonist-stimulated [35S]GTP gamma S binding in rat brain regions. Neuropharmacology 42:1031-1038.
139. Sherwin BB (2007). The clinical relevance of the relationship between estrogen and cognition in women. J Steroid Biochem Mol Biol 106:151-156.
140. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261.
141. Shughrue PJ, Lane MV, Merchenthaler I (1997). Comparative distribution of estrogen receptor-alpha and-beta mRNA in the rat central nervous system. J Comp Neurol 388:507-525.
142. Singh M, Meyer EM, Simpkins JW (1995). The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136:2320-2324.
143. Soares CN, Almeida OP, Joffe H, Cohen LS (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58:529-534.
144. Sohrabji F, Lewis DK (2006). Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front Neuroendocrinol 27:404-414.
145. Solomon MB, Herman JP (2009). Sex differences in psychopathology: of gonads, adrenals and mental illness. Physiol & Behav 97:250-258.
146. Tanapat P, Hastings NB, Reeves AJ, Gould E (1999). Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J Neurosci 19:5792-5801.
147. Tena-Sempere M, Navarro VM, Mayen A, Bellido C, Sánchez-Criado JE (2004). Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary. Biol Reprod 70:671-678.
148. Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S, et al. (2000). cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20:4030-4036.
149. Toran-Allerand CD (2004). Minireview: a plethora of estrogen receptors in the brain: where will it end? Endocrinology 145:1069-1074.
150. Toran-Allerand CD, Singh M, Setalo G Jr (1999). Novel mechanisms of estrogen action in the brain: new players in an old story. Front Neuroendocrinol 20:97-121.
151. Toran-Allerand CD, Tinnikov AA, Singh RJ, Nethrapalli IS (2005). 17alpha-estradiol: a brain-active estrogen? Endocrinology 146:3843-3850.
152. Vasudevan N, Pfaff DW (2007). Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocr Rev 28:1-19.
153. Vega N, López-Rubalcava C, Estrada-Camarena E (2008). Participation of the serotonergic system in the antidepressant-like actions of ethynil estradiol in the forced swimming test. Program No. 56.4/BB9 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience. Online.
154. Walf AA, Frye CA (2005a). Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology 30:1288-1301.
155. Walf AA, Frye CA (2005b). ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariecto-mized rats. Neuropsychopharmacology 30:1598-1609.
156. Walf AA, Frye CA (2006). A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsy-chopharmacology 31:1097-1111.
157. Walf AA, Frye CA (2007). Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 86:407-414.
158. Walf AA, Frye CA (2008). Parity and estrogen-administration alter affective behavior of ovariectomized rats. Physiol Behav 93:351-356.
159. Walf AA, Frye CA (2010a). Raloxifene and/or estradiol decrease anxiety-like and depressive-like behavior, whereas only estradiol increases carcinogen-induced tumorigenesis and uterine proliferation among ovariectomized rats. Behav Pharmacol 21:231-240.
160. Walf AA, Frye CA (2010b). Estradiol reduces anxiety-and depression-like behavior of aged female mice. Physiol Behav 99:169-174.
161. Walf AA, Rhodes ME, Frye CA (2004). Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test. Pharmacol Biochem Behav 78:523-529.
162. Walf AA, Ciriza I, Garcia-Segura LM, Frye CA (2007). Antisense oligodeox-ynucleotides for estrogen receptor-beta and alpha attenuate estradiol's modulation of affective and sexual behavior, respectively. Neuropsychophar-macology 33:431-440.
163. Walf AA, Paris JJ, Frye CA (2009). Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance. Psychoneuroendocrinology 34:909-916.
164. Wang SH, Zhang ZJ, Guo YJ, Teng GJ, Chen BA (2008). Hippocampal
165. Weiser MJ, Foradori CD, Handa RJ (2008). Estrogen receptor beta in the brain: from form to function. Brain Res Rev 57:309-320.
166. Willner P (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsy-chobiology 52:90-110.
167. Xu H, Qin S, Carrasco GA, Dai Y, Filardo EJ, Prossnitz ER, et al. (2009). Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus. Neuroscience 158:1599-1607.
168. Yamaguchi-Shima N, Yuri K (2007). Age-related changes in the expression of ER-beta mRNA in the female rat brain. Brain Res 1155:34-41.
169. Zhang JQ, Cai WQ, Zhou DS, Su BY (2002). Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats. Brain Res 935:73-80.
170. Zhou J, Cohen RS, Pandey SC (2001). Estrogen affects the expression of Ca2 +/calmodulin-dependent protein kinase IV in amygdala. Neuroreport 12:2987-2990.